APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neutral Alternative Protein

Alternative proteins, such as plant-based meat substitutes and edible insects, provide a substantial amount of protein but require less natural inputs to produce then the most common protein sources, meat and fish. Composed of different sequences of amino acids, proteins are found in almost all whole foods. Protein is responsible for building lean body tissue and providing the elements needed for digestive enzymes. Certain plant-based proteins offer functionality but pose flavor challenges. Pea protein is becoming more popular in part because of its neutral flavor.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Alternative proteins, such as plant-based meat substitutes and edible insects, provide a substantial amount of protein but require less natural inputs to produce then the most common protein sources, meat and fish. Composed of different sequences of amino acids, proteins are found in almost all whole foods. Protein is responsible for building lean body tissue and providing the elements needed for digestive enzymes. Certain plant-based proteins offer functionality but pose flavor challenges. Pea protein is becoming more popular in part because of its neutral flavor.

Selected research

Market Outlook & Growth Opportunities

Global Neutral Alternative Protein Market Outlook and Growth Opportunities 2026

9 January 2026199 pages

Choose your research edition.

Industry ResearchNeutral Alternative Protein Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Neutral Alternative Protein Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Neutral Alternative Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neutral Alternative Protein Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Neutral Alternative Protein Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Alternative proteins, such as plant-based meat substitutes and edible insects, provide a substantial amount of protein but require less natural inputs to produce then the most common protein sources, meat and fish. Composed of different sequences of amino acids, proteins are found in almost all whole foods. Protein is responsible for building lean body tissue and providing the elements needed for digestive enzymes. Certain plant-based proteins offer functionality but pose flavor challenges. Pea protein is becoming more popular in part because of its neutral flavor.

Global Neutral Alternative Protein key players include Kerry, Cargill, Archer Daniels Midland, Glanbia, CHS etc. Global top five manufacturers hold a share over 30%.

North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share over 40% percent.

Read the full market overview

In terms of product, Plant Protein is the largest segment, with a share over 50%. And in terms of application, the largest application is Food & Beverage followed by Healthcare Product.

This report provides an overview of the global Neutral Alternative Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neutral Alternative Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neutral Alternative Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Neutral Alternative Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Neutral Alternative Protein Segment by Company

Kerry

Cargill

Archer Daniels Midland

Glanbia

CHS

Tereos Syral

CP Kelco

Davisco

Meelunie

DuPont

MGP Ingredient

Taj Agro Product

Glico Nutrition

Neutral Alternative Protein Segment by Type

Plant Protein

Insect Protein

Algae Protein

Others

Neutral Alternative Protein Segment by Application

Food & Beverage

Healthcare product

Neutral Alternative Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neutral Alternative Protein status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Neutral Alternative Protein market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neutral Alternative Protein significant trends, drivers, influence factors in global and regions.

6. To analyze Neutral Alternative Protein competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neutral Alternative Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neutral Alternative Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neutral Alternative Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Neutral Alternative Protein market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neutral Alternative Protein industry.

Chapter 3: Detailed analysis of Neutral Alternative Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Neutral Alternative Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Neutral Alternative Protein in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neutral Alternative Protein Industry Trends Table 2. Neutral Alternative Protein Industry Drivers Table 3. Neutral Alternative Protein Industry Opportunities and Challenges Table 4. Neutral Alternative Protein Industry Restraints Table 5. Global Neutral Alternative Protein Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neutral Alternative Protein Revenue Share by Company (2021-2026) Table 7. Global Neutral Alternative Protein Sales Volume by Company (K MT) & (2021-2026) Table 8. Global Neutral Alternative Protein Sales Volume Share by Company (2021-2026) Table 9. Global Neutral Alternative Protein Average Price (USD/MT) of Company (2021-2026) Table 10. Global Neutral Alternative Protein Company Ranking, (2024-2026) & (USD Million) Table 11. Global Neutral Alternative Protein Key Company Manufacturing Base & Headquarters Table 12. Global Neutral Alternative Protein Company, Product Type & Application Table 13. Global Neutral Alternative Protein Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Neutral Alternative Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plant Protein Table 18. Significant Companies of Insect Protein Table 19. Significant Companies of Algae Protein Table 20. Significant Companies of Others Table 21. Global Neutral Alternative Protein Sales Volume by Type 2021 VS 2025 VS 2032 (K MT) Table 22. Global Neutral Alternative Protein Sales Volume by Type (2021-2026) & (K MT) Table 23. Global Neutral Alternative Protein Sales Volume by Type (2027-2032) & (K MT) Table 24. Global Neutral Alternative Protein Sales Volume Share by Type (2021-2026) Table 25. Global Neutral Alternative Protein Sales Volume Share by Type (2027-2032) Table 26. Global Neutral Alternative Protein Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Neutral Alternative Protein Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Neutral Alternative Protein Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Neutral Alternative Protein Sales Value Share by Type (2021-2026) Table 30. Global Neutral Alternative Protein Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Food & Beverage Table 32. Significant Companies of Healthcare product Table 33. Global Neutral Alternative Protein Sales Volume by Application 2021 VS 2025 VS 2032 (K MT) Table 34. Global Neutral Alternative Protein Sales Volume by Application (2021-2026) & (K MT) Table 35. Global Neutral Alternative Protein Sales Volume by Application (2027-2032) & (K MT) Table 36. Global Neutral Alternative Protein Sales Volume Share by Application (2021-2026) Table 37. Global Neutral Alternative Protein Sales Volume Share by Application (2027-2032) Table 38. Global Neutral Alternative Protein Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Neutral Alternative Protein Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Neutral Alternative Protein Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Neutral Alternative Protein Sales Value Share by Application (2021-2026) Table 42. Global Neutral Alternative Protein Sales Value Share by Application (2027-2032) Table 43. Global Neutral Alternative Protein Sales by Region: 2021 VS 2025 VS 2032 (K MT) Table 44. Global Neutral Alternative Protein Sales by Region (2021-2026) & (K MT) Table 45. Global Neutral Alternative Protein Sales Market Share by Region (2021-2026) Table 46. Global Neutral Alternative Protein Sales by Region (2027-2032) & (K MT) Table 47. Global Neutral Alternative Protein Sales Market Share by Region (2027-2032) Table 48. Global Neutral Alternative Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Neutral Alternative Protein Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Neutral Alternative Protein Sales Value Share by Region (2021-2026) Table 51. Global Neutral Alternative Protein Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Neutral Alternative Protein Sales Value Share by Region (2027-2032) Table 53. Global Neutral Alternative Protein Market Average Price (USD/MT) by Region (2021-2026) Table 54. Global Neutral Alternative Protein Market Average Price (USD/MT) by Region (2027-2032) Table 55. Global Neutral Alternative Protein Sales by Country: 2021 VS 2025 VS 2032 (K MT) Table 56. Global Neutral Alternative Protein Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Neutral Alternative Protein Sales by Country (2021-2026) & (K MT) Table 58. Global Neutral Alternative Protein Sales Market Share by Country (2021-2026) Table 59. Global Neutral Alternative Protein Sales by Country (2027-2032) & (K MT) Table 60. Global Neutral Alternative Protein Sales Market Share by Country (2027-2032) Table 61. Global Neutral Alternative Protein Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Neutral Alternative Protein Sales Value Market Share by Country (2021-2026) Table 63. Global Neutral Alternative Protein Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Neutral Alternative Protein Sales Value Market Share by Country (2027-2032) Table 65. Kerry Company Information Table 66. Kerry Business Overview Table 67. Kerry Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 68. Kerry Neutral Alternative Protein Product Portfolio Table 69. Kerry Recent Development Table 70. Cargill Company Information Table 71. Cargill Business Overview Table 72. Cargill Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 73. Cargill Neutral Alternative Protein Product Portfolio Table 74. Cargill Recent Development Table 75. Archer Daniels Midland Company Information Table 76. Archer Daniels Midland Business Overview Table 77. Archer Daniels Midland Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 78. Archer Daniels Midland Neutral Alternative Protein Product Portfolio Table 79. Archer Daniels Midland Recent Development Table 80. Glanbia Company Information Table 81. Glanbia Business Overview Table 82. Glanbia Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 83. Glanbia Neutral Alternative Protein Product Portfolio Table 84. Glanbia Recent Development Table 85. CHS Company Information Table 86. CHS Business Overview Table 87. CHS Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 88. CHS Neutral Alternative Protein Product Portfolio Table 89. CHS Recent Development Table 90. Tereos Syral Company Information Table 91. Tereos Syral Business Overview Table 92. Tereos Syral Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 93. Tereos Syral Neutral Alternative Protein Product Portfolio Table 94. Tereos Syral Recent Development Table 95. CP Kelco Company Information Table 96. CP Kelco Business Overview Table 97. CP Kelco Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 98. CP Kelco Neutral Alternative Protein Product Portfolio Table 99. CP Kelco Recent Development Table 100. Davisco Company Information Table 101. Davisco Business Overview Table 102. Davisco Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 103. Davisco Neutral Alternative Protein Product Portfolio Table 104. Davisco Recent Development Table 105. Meelunie Company Information Table 106. Meelunie Business Overview Table 107. Meelunie Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 108. Meelunie Neutral Alternative Protein Product Portfolio Table 109. Meelunie Recent Development Table 110. DuPont Company Information Table 111. DuPont Business Overview Table 112. DuPont Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 113. DuPont Neutral Alternative Protein Product Portfolio Table 114. DuPont Recent Development Table 115. MGP Ingredient Company Information Table 116. MGP Ingredient Business Overview Table 117. MGP Ingredient Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 118. MGP Ingredient Neutral Alternative Protein Product Portfolio Table 119. MGP Ingredient Recent Development Table 120. Taj Agro Product Company Information Table 121. Taj Agro Product Business Overview Table 122. Taj Agro Product Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 123. Taj Agro Product Neutral Alternative Protein Product Portfolio Table 124. Taj Agro Product Recent Development Table 125. Glico Nutrition Company Information Table 126. Glico Nutrition Business Overview Table 127. Glico Nutrition Neutral Alternative Protein Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 128. Glico Nutrition Neutral Alternative Protein Product Portfolio Table 129. Glico Nutrition Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Neutral Alternative Protein Distributors List Table 133. Neutral Alternative Protein Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Neutral Alternative Protein Product Image Figure 2. Global Neutral Alternative Protein Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neutral Alternative Protein Sales Value (2021-2032) & (US$ Million) Figure 4. Global Neutral Alternative Protein Sales (2021-2032) & (K MT) Figure 5. Global Neutral Alternative Protein Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global Neutral Alternative Protein Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plant Protein Image Figure 10. Insect Protein Image Figure 11. Algae Protein Image Figure 12. Others Image Figure 13. Global Neutral Alternative Protein Sales Volume by Type (2021 VS 2025 VS 2032) & (K MT) Figure 14. Global Neutral Alternative Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Neutral Alternative Protein Sales Volume Share by Type (2021-2032) Figure 16. Global Neutral Alternative Protein Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Neutral Alternative Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Neutral Alternative Protein Sales Value Share by Type (2021-2032) Figure 19. Food & Beverage Image Figure 20. Healthcare product Image Figure 21. Global Neutral Alternative Protein Sales Volume by Application (2021 VS 2025 VS 2032) & (K MT) Figure 22. Global Neutral Alternative Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Neutral Alternative Protein Sales Volume Share by Application (2021-2032) Figure 24. Global Neutral Alternative Protein Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Neutral Alternative Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Neutral Alternative Protein Sales Value Share by Application (2021-2032) Figure 27. Global Neutral Alternative Protein Sales by Region: 2021 VS 2025 VS 2032 (K MT) Figure 28. Global Neutral Alternative Protein Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Neutral Alternative Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Neutral Alternative Protein Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Neutral Alternative Protein Sales Value (2021-2032) & (US$ Million) Figure 32. North America Neutral Alternative Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Neutral Alternative Protein Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Neutral Alternative Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Neutral Alternative Protein Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Neutral Alternative Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Neutral Alternative Protein Sales Value (2021-2032) & (US$ Million) Figure 38. South America Neutral Alternative Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Neutral Alternative Protein Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Neutral Alternative Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Neutral Alternative Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Neutral Alternative Protein Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Neutral Alternative Protein Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Protein
  • Insect Protein
  • Algae Protein
  • Others
Applications
  • Food & Beverage
  • Healthcare product
Companies covered
  • Kerry
  • Cargill
  • Archer Daniels Midland
  • Glanbia
  • CHS
  • Tereos Syral
  • CP Kelco
  • Davisco
  • Meelunie
  • DuPont
  • MGP Ingredient
  • Taj Agro Product
  • Glico Nutrition

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neutral Alternative Protein Sales Value (2021-2032)
  4. 1.2.2 Global Neutral Alternative Protein Sales Volume (2021-2032)
  5. 1.2.3 Global Neutral Alternative Protein Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Neutral Alternative Protein Market Dynamics
  1. 2.1 Neutral Alternative Protein Industry Trends
  2. 2.2 Neutral Alternative Protein Industry Drivers
  3. 2.3 Neutral Alternative Protein Industry Opportunities and Challenges
  4. 2.4 Neutral Alternative Protein Industry Restraints
3 Neutral Alternative Protein Market by Company
  1. 3.1 Global Neutral Alternative Protein Company Revenue Ranking in 2025
  2. 3.2 Global Neutral Alternative Protein Revenue by Company (2021-2026)
  3. 3.3 Global Neutral Alternative Protein Sales Volume by Company (2021-2026)
  4. 3.4 Global Neutral Alternative Protein Average Price by Company (2021-2026)
  5. 3.5 Global Neutral Alternative Protein Company Ranking (2024-2026)
  6. 3.6 Global Neutral Alternative Protein Company Manufacturing Base and Headquarters
  7. 3.7 Global Neutral Alternative Protein Company Product Type and Application
  8. 3.8 Global Neutral Alternative Protein Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Neutral Alternative Protein Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Neutral Alternative Protein Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Neutral Alternative Protein Market by Type
  1. 4.1 Neutral Alternative Protein Type Introduction
  2. 4.1.1 Plant Protein
  3. 4.1.2 Insect Protein
  4. 4.1.3 Algae Protein
  5. 4.1.4 Others
  6. 4.2 Global Neutral Alternative Protein Sales Volume by Type
  7. 4.2.1 Global Neutral Alternative Protein Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neutral Alternative Protein Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Neutral Alternative Protein Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Neutral Alternative Protein Sales Value by Type
  11. 4.3.1 Global Neutral Alternative Protein Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Neutral Alternative Protein Sales Value by Type (2021-2032)
  13. 4.3.3 Global Neutral Alternative Protein Sales Value Share by Type (2021-2032)
5 Neutral Alternative Protein Market by Application
  1. 5.1 Neutral Alternative Protein Application Introduction
  2. 5.1.1 Food & Beverage
  3. 5.1.2 Healthcare product
  4. 5.2 Global Neutral Alternative Protein Sales Volume by Application
  5. 5.2.1 Global Neutral Alternative Protein Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Neutral Alternative Protein Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Neutral Alternative Protein Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Neutral Alternative Protein Sales Value by Application
  9. 5.3.1 Global Neutral Alternative Protein Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Neutral Alternative Protein Sales Value by Application (2021-2032)
  11. 5.3.3 Global Neutral Alternative Protein Sales Value Share by Application (2021-2032)
6 Neutral Alternative Protein Regional Sales and Value Analysis
  1. 6.1 Global Neutral Alternative Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neutral Alternative Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Neutral Alternative Protein Sales by Region: 2021-2026
  4. 6.2.2 Global Neutral Alternative Protein Sales by Region (2027-2032)
  5. 6.3 Global Neutral Alternative Protein Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Neutral Alternative Protein Sales Value by Region (2021-2032)
  7. 6.4.1 Global Neutral Alternative Protein Sales Value by Region: 2021-2026
  8. 6.4.2 Global Neutral Alternative Protein Sales Value by Region (2027-2032)
  9. 6.5 Global Neutral Alternative Protein Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Neutral Alternative Protein Sales Value (2021-2032)
  12. 6.6.2 North America Neutral Alternative Protein Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Neutral Alternative Protein Sales Value (2021-2032)
  15. 6.7.2 Europe Neutral Alternative Protein Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Neutral Alternative Protein Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Neutral Alternative Protein Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Neutral Alternative Protein Sales Value (2021-2032)
  21. 6.9.2 South America Neutral Alternative Protein Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Neutral Alternative Protein Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Neutral Alternative Protein Sales Value Share by Country, 2025 VS 2032
7 Neutral Alternative Protein Country-level Sales and Value Analysis
  1. 7.1 Global Neutral Alternative Protein Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neutral Alternative Protein Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Neutral Alternative Protein Sales by Country (2021-2032)
  4. 7.3.1 Global Neutral Alternative Protein Sales by Country (2021-2026)
  5. 7.3.2 Global Neutral Alternative Protein Sales by Country (2027-2032)
  6. 7.4 Global Neutral Alternative Protein Sales Value by Country (2021-2032)
  7. 7.4.1 Global Neutral Alternative Protein Sales Value by Country (2021-2026)
  8. 7.4.2 Global Neutral Alternative Protein Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Neutral Alternative Protein Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Neutral Alternative Protein Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Neutral Alternative Protein Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kerry
  2. 8.1.1 Kerry Company Information
  3. 8.1.2 Kerry Business Overview
  4. 8.1.3 Kerry Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Kerry Neutral Alternative Protein Product Portfolio
  6. 8.1.5 Kerry Recent Developments
  7. 8.2 Cargill
  8. 8.2.1 Cargill Company Information
  9. 8.2.2 Cargill Business Overview
  10. 8.2.3 Cargill Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cargill Neutral Alternative Protein Product Portfolio
  12. 8.2.5 Cargill Recent Developments
  13. 8.3 Archer Daniels Midland
  14. 8.3.1 Archer Daniels Midland Company Information
  15. 8.3.2 Archer Daniels Midland Business Overview
  16. 8.3.3 Archer Daniels Midland Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Archer Daniels Midland Neutral Alternative Protein Product Portfolio
  18. 8.3.5 Archer Daniels Midland Recent Developments
  19. 8.4 Glanbia
  20. 8.4.1 Glanbia Company Information
  21. 8.4.2 Glanbia Business Overview
  22. 8.4.3 Glanbia Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Glanbia Neutral Alternative Protein Product Portfolio
  24. 8.4.5 Glanbia Recent Developments
  25. 8.5 CHS
  26. 8.5.1 CHS Company Information
  27. 8.5.2 CHS Business Overview
  28. 8.5.3 CHS Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CHS Neutral Alternative Protein Product Portfolio
  30. 8.5.5 CHS Recent Developments
  31. 8.6 Tereos Syral
  32. 8.6.1 Tereos Syral Company Information
  33. 8.6.2 Tereos Syral Business Overview
  34. 8.6.3 Tereos Syral Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tereos Syral Neutral Alternative Protein Product Portfolio
  36. 8.6.5 Tereos Syral Recent Developments
  37. 8.7 CP Kelco
  38. 8.7.1 CP Kelco Company Information
  39. 8.7.2 CP Kelco Business Overview
  40. 8.7.3 CP Kelco Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CP Kelco Neutral Alternative Protein Product Portfolio
  42. 8.7.5 CP Kelco Recent Developments
  43. 8.8 Davisco
  44. 8.8.1 Davisco Company Information
  45. 8.8.2 Davisco Business Overview
  46. 8.8.3 Davisco Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Davisco Neutral Alternative Protein Product Portfolio
  48. 8.8.5 Davisco Recent Developments
  49. 8.9 Meelunie
  50. 8.9.1 Meelunie Company Information
  51. 8.9.2 Meelunie Business Overview
  52. 8.9.3 Meelunie Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Meelunie Neutral Alternative Protein Product Portfolio
  54. 8.9.5 Meelunie Recent Developments
  55. 8.10 DuPont
  56. 8.10.1 DuPont Company Information
  57. 8.10.2 DuPont Business Overview
  58. 8.10.3 DuPont Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 DuPont Neutral Alternative Protein Product Portfolio
  60. 8.10.5 DuPont Recent Developments
  61. 8.11 MGP Ingredient
  62. 8.11.1 MGP Ingredient Company Information
  63. 8.11.2 MGP Ingredient Business Overview
  64. 8.11.3 MGP Ingredient Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 MGP Ingredient Neutral Alternative Protein Product Portfolio
  66. 8.11.5 MGP Ingredient Recent Developments
  67. 8.12 Taj Agro Product
  68. 8.12.1 Taj Agro Product Company Information
  69. 8.12.2 Taj Agro Product Business Overview
  70. 8.12.3 Taj Agro Product Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Taj Agro Product Neutral Alternative Protein Product Portfolio
  72. 8.12.5 Taj Agro Product Recent Developments
  73. 8.13 Glico Nutrition
  74. 8.13.1 Glico Nutrition Company Information
  75. 8.13.2 Glico Nutrition Business Overview
  76. 8.13.3 Glico Nutrition Neutral Alternative Protein Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Glico Nutrition Neutral Alternative Protein Product Portfolio
  78. 8.13.5 Glico Nutrition Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Neutral Alternative Protein Value Chain Analysis
  2. 9.1.1 Neutral Alternative Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Neutral Alternative Protein Sales Mode & Process
  6. 9.2 Neutral Alternative Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Neutral Alternative Protein Distributors
  9. 9.2.3 Neutral Alternative Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst